EB01 Cream 0.2%

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Evaluation of EB01 Cream for the Treatment of Chronic Allergic Contact DermatitisNCT03680131EDSAPhase 2Completed2022-09-21Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.